Official SEC submissions

BioRestorative Therapies SEC Filings

Direct answer

BioRestorative Therapies's latest SEC filing is 8-K.

It was filed on September 2, 2026, and 40 recent filings are available.

Each row links directly to the SEC document and filing index.

Official SEC EDGAR submissions

Get free BioRestorative Therapies email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Recent SEC filings

8-K

Current report

Filed: 2026-09-02

Report date: 2026-09-02

CURRENT REPORT

Open SEC document View filing index

8-K

Current report

Filed: 2026-09-02

Report date: 2026-08-26

CURRENT REPORT

Open SEC document View filing index

8-K

Current report

Filed: 2026-08-25

Report date: 2026-08-21

CURRENT REPORT

Open SEC document View filing index

8-K

Current report

Filed: 2026-08-14

Report date: 2026-08-07

8-K

Open SEC document View filing index

8-K

Current report

Filed: 2026-07-16

Report date: 2026-07-08

8-K

Open SEC document View filing index

8-K

Current report

Filed: 2026-06-12

Report date: 2026-06-10

CURRENT REPORT FILING

Open SEC document View filing index

8-K

Current report

Filed: 2026-06-12

Report date: 2026-06-10

CURRENT REPORT FILING

Open SEC document View filing index

8-K

Current report

Filed: 2026-05-29

Report date: 2026-05-26

FORM 8-K DATED MARCH 26, 2026

Open SEC document View filing index

10-Q

Periodic report

Filed: 2026-05-14

Report date: 2026-03-31

10-Q

Open SEC document View filing index

8-K

Current report

Filed: 2026-05-01

Report date: 2026-05-01

CURRENT REPORT FILING

Open SEC document View filing index

8-K

Current report

Filed: 2026-04-23

Report date: 2026-04-23

CURRENT REPORT FILING

Open SEC document View filing index

DEF 14A

Proxy statement

Filed: 2026-04-13

Report date: 2026-05-26

Open SEC document View filing index

10-K

Periodic report

Filed: 2026-03-26

Report date: 2025-12-31

10-K

Open SEC document View filing index

8-K

Current report

Filed: 2026-02-17

Report date: 2026-02-11

8-K

Open SEC document View filing index

S-1/A

Registration statement

Filed: 2026-02-10

S-1/A

Open SEC document View filing index

S-1

Registration statement

Filed: 2026-02-09

S-1

Open SEC document View filing index

S-1

Registration statement

Filed: 2025-11-18

S-1

Open SEC document View filing index

10-Q

Periodic report

Filed: 2025-11-12

Report date: 2025-09-30

10-Q

Open SEC document View filing index

8-K

Current report

Filed: 2025-11-12

Report date: 2025-11-12

THIRD QUARTER 2025 FINANCIAL RESULTS

Open SEC document View filing index

Insider transaction

Filed: 2025-10-20

Report date: 2025-10-06

Open SEC document View filing index

Insider transaction

Filed: 2025-10-20

Report date: 2025-10-06

Open SEC document View filing index

8-K

Current report

Filed: 2025-10-08

Report date: 2025-10-06

8-K

Open SEC document View filing index

8-K

Current report

Filed: 2025-09-25

Report date: 2025-09-18

ANNUAL MEETING VOTE

Open SEC document View filing index

8-K

Current report

Filed: 2025-08-14

Report date: 2025-08-14

PRESENTATION MATERIALS

Open SEC document View filing index

10-Q

Periodic report

Filed: 2025-08-12

Report date: 2025-06-30

10-Q

Open SEC document View filing index

8-K

Current report

Filed: 2025-08-12

Report date: 2025-08-12

Q2 2025 EARNINGS, BUSINESS UPDATE AND CONFERENCE CALL

Open SEC document View filing index

DEF 14A

Proxy statement

Filed: 2025-08-08

Report date: 2025-08-08

DEF 14A

Open SEC document View filing index

8-K

Current report

Filed: 2025-06-13

Report date: 2025-06-13

PRESENTATION - INTERNATIONAL SOCIETY FOR STEM CELL RESEARCH

Open SEC document View filing index

10-Q

Periodic report

Filed: 2025-05-14

Report date: 2025-03-31

10-Q

Open SEC document View filing index

8-K

Current report

Filed: 2025-05-14

Report date: 2025-05-14

FIRST QUARTER 2025 AND BUSINESS UPDATE CONFERENCE CALL

Open SEC document View filing index

8-K

Current report

Filed: 2025-04-21

Report date: 2025-04-16

CHANGE IN ACCOUNTANTS

Open SEC document View filing index

10-K

Periodic report

Filed: 2025-03-28

Report date: 2024-12-31

Open SEC document View filing index

8-K

Current report

Filed: 2025-03-27

Report date: 2025-03-27

FINANCIAL RESULTS YEAR ENDED DECEMBER 31, 2024 AND CONFERENCE CALL

Open SEC document View filing index

Insider transaction

Filed: 2025-02-19

Report date: 2025-02-14

Open SEC document View filing index

Insider transaction

Filed: 2025-02-19

Report date: 2025-02-14

Open SEC document View filing index

Insider transaction

Filed: 2025-02-19

Report date: 2025-02-14

Open SEC document View filing index

Insider transaction

Filed: 2025-02-19

Report date: 2025-02-14

Open SEC document View filing index

Insider transaction

Filed: 2025-02-19

Report date: 2025-02-14

Open SEC document View filing index

Insider transaction

Filed: 2025-02-19

Report date: 2025-02-14

Open SEC document View filing index

8-K

Current report

Filed: 2025-02-10

Report date: 2025-02-10

ORS PRESENTATION

Open SEC document View filing index

Verified data

Recent filing categories: 5
Recent filings: 40
SEC CIK: 0001505497
Latest filing date: September 2, 2026

Explore related company data

View the BioRestorative Therapies company profile View BioRestorative Therapies annual financials